Skip to main content

MusclePharm Corporation to Present at The MicroCap Conference on October 2, 2018

BURBANK, CA / ACCESSWIRE / September 25, 2018 / MusclePharm® Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically driven, performance-lifestyle sports nutrition company, announces that management will present at The MicroCap Conference on Tuesday, October 2, 2018 at 11:00 a.m. Eastern time (8:00 a.m. Pacific time). The conference is being held at the Essex House in New York City.

Management will be available for one-on-one meetings with the investment community on Tuesday, October 2, 2018. Please contact The MicroCap Conference at https://microcapconf.com/ to arrange a meeting.

A live webcast and replay of the presentation will be available on the events section of the Company's website at http://ir.musclepharmcorp.com/MSLP/events/2181.

About MusclePharm Corporation

MusclePharm® develops, manufactures, markets and distributes branded nutritional supplements. Its portfolio of recognized brands includes MusclePharm® Sport Series, Essential Series, FitMiss™, as well as Natural Series, which was launched in 2017. These products are available in more than 100 countries worldwide. MusclePharm is an innovator in the sports nutrition industry with clinically proven supplements that are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. For more information, visit http://www.musclepharmcorp.com. To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts.

Contact:

LHA Investor Relations
Jody Cain jcain@lhai.com
Kevin Mc Cabe kmccabe@lhai.com
310-691-7100

SOURCE: MusclePharm Corporation



View source version on accesswire.com:
https://www.accesswire.com/512758/MusclePharm-Corporation-to-Present-at-The-MicroCap-Conference-on-October-2-2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.